2021

        Lei Zhang

        Hongliang Zong

        Xia Guo

        Rudolf Li

        China Biotech Industry: Six foreign-invested enterprises gain approval to engage in stem cell research activities

        【Reprinted from Han Kun Law Offices】China Pilots Lifting Restrictions on Foreign Investment in Stem Cell, Gene Therapy, and Genetic Diagnosis Sectors in Four Free Trade Zones

        Richard Liqun Wang: China's Cell and Gene Therapy Poised to Take the Lead

        Neukio Biotherapeutics and Tofflon Life Sciences Successfully Deliver Customized Glass Bioreactors

        Richard Wang: A Seventeen-Year Odyssey of an Overseas PhD Returnee in the Pursuit of Domestic Innovative Drug Development

        Richard Wang: Perks enjoyed by companies based in the FTZ

        Neukio Biotherapeutics Reached Strategic Collaboration with Tofflon Science and Technology Group Co. Ltd to Expedite Large-scale Production of Next Generation Allogenic Cell Therapies

        Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products

        EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell Therapies

        Neukio Biotherapeutics has completed $40m Angel round of financing and is committed to developing new NK technology platform and products